Piriformis SyndromePiriformisNCT07322185
Comparative Effects of Stecco-fascial Manipulation and Rolfing Structural Integration in Patients With Piriformis Syndrome
A study testing Experimental: GROUP A ( Stecco fascial Manipulation) and Experimental: GROUP B (Rolfing Structural Integration) in people with Piriformis Syndrome, run by Danyal Ahmad at 3 sites in Pakistan.
Trial summary
This study aims to compare the effectiveness of Stecco Fascial Manipulation and Rolfing Structural Integration in treating Piriformis syndrome, focusing on special outcomes like pain severity and functional outcomes. Read more about this study
- Who is it for?
- Ages 25 to 45 years
- Conditions the study is for
- Piriformis Syndrome
- What is being tested?
- Experimental: GROUP A ( Stecco fascial Manipulation) and Experimental: GROUP B (Rolfing Structural Integration)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 42 participants
- Where
- 3 sitesPakistan
- Study dates
- 1 Mar 2025to 30 Aug 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 45 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- 25 to 45 age group.
- For at least four weeks, there has been unilateral buttock discomfort, either with or without posterior thigh pain included buttock pain, pain that worsened when sitting.
- Positive slump test and fair test decrease ranges of hip NPRS greater than
Who cannot join
- Previous pelvic, ipsilateral hip, lumbar, or sacroiliac surgery that would have confused pain source.
- Evidence of lumbar radiculopathy or another spinal condition that could be the origin of the symptoms (matching MRI/CT revealing nerve root compression or disc herniation). progressive neurologic disease or neuromuscular disease (e.g., peripheral neuropathy, myopathy, neuromuscular junction diseases)28.
- During the research period, pregnancy or the planning of pregnancy (if interventions are employed) active pelvic or hip infection, malignancy, fracture, or systemic inflammation.
Trial locations and contacts
3 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan3 sites
Raheem Surgical Hospital Sambrial
Sambrial, Punjab Province, 51040
Bethania Hospital Sialkot
Sialkot, Punjab Province, 51310
University of Management and technology Sialkot Campus
Sialkot, Punjab Province, 51310
About this study
Official title: COMPARATIVE EFFECTS OF STECCO-FASCIAL MANIPULATION AND ROLFING STRUCTURAL INTEGRATION IN PATIENTS WITH PIRIFORMIS SYNDROME; A RANDOMIZED CLINICAL TRIAL
This study aims to compare the effectiveness of Stecco Fascial Manipulation and Rolfing Structural Integration in treating Piriformis syndrome, focusing on special outcomes like pain severity and functional outcomes.
comparison will be done to check the effectiveness of Stecco-fascial Manipulation and Rolfing Structural Integration on patients of both groups.
participants will:
- get the treatment according to their respective groups
- Both groups were given 4 sessions for 4 weeks.
Read the detailed description
This study will be a randomized clinical trial with a sample size of 42 participants as calculated with g power tool with 5% of attrition added. Subjects will be obtained by non- probability convenient sampling based on the inclusion and exclusion criteria. Participants will be randomly assigned into two groups, 21 subjects in each group. The group A will receive the stecco fascial manipulation along with the conventional therapy while group B will receive the rolfing structural integration along with conventional therapy. The conventional physiotherapy protocol will include TENS applied with a Hot- pack for 10 minutes that will be followed by piriformis stretch.The data analysis will be done by IBM SPSS 26.0 version. To check the normality Shaprio- Wilk test will be used.
- Conditions
- Piriformis Syndrome
- Being tested
- Experimental: GROUP A ( Stecco fascial Manipulation), Experimental: GROUP B (Rolfing Structural Integration)
- Keywords
- Stecco-fascial Manipulation, Rolfing Structural Integration, Piriformis Muscle Syndrome, Manual Lymphatic Drainage, Muscle Recruitment
- Medical subject headings
- Piriformis Muscle Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Experimental: GROUP A ( Stecco fascial Manipulation)Other
Stecco-fascial manipulation primary reduces pain, improves range of motion, restores normal muscle recruitment link in myofascial sequences, facilitates healing by improving microcirculation and lymphatic drainage.
Experimental: GROUP B (Rolfing Structural Integration)Other
Rolfing structural integration improves posture, reduces pain, lengthens fascial planes and enhances the movement efficiency. This research will determine which approach is more effective in treating the patient with piriformis syndrome.
| Study group | Role | What they receive |
|---|---|---|
| GROUP A ( Stecco fascial Manipulation) | Experimental | GROUP A ( Stecco fascial Manipulation) containing 21 participants who will be given Stecco fascial Manipulation for 30 minutes along with the conventional physiotherapy. Receives: Other: Experimental: GROUP A ( Stecco fascial Manipulation) |
| GROUP B (Rolfing Structural Integration) | Experimental | GROUP B (Rolfing Structural Integration) containing 21 participants who were given Rolfing Structural Integration for 30 minutes along with the conventional physiotherapy. Receives: Other: Experimental: GROUP B (Rolfing Structural Integration) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change From Baseline in Pain Intensity as Measured by the Numerical Pain Rating Rating Scale (NPRS)
The Numerical Pain Rating Scale (NPRS) is a self-intensity on an 11-point scale, ranging from 0 (no pain) to 10 (worst possible pain). It is widely used in both clinical and research demonstrated strong reliability and validity in measuring Scale (NPRS) is a self-reported tool used to assess pain point scale, ranging from 0 (no pain) to 10 (worst possible pain). It is research settings for musculoskeletal conditions, strong reliability and validity in measuring both acute and chronic pain reported tool used to assess pain point scale, ranging from 0 (no pain) to 10 (worst possible pain). It is conditions, and it has both acute and chronic pain
Measured: 4 Weeks
Universal Goniometer
A goniometer is an instrument used objective and reliable values that help evaluate mobility limitations i disorders such as piriformis syndrome used to measure joint range of motion (ROM). It provides objective and reliable values that help evaluate mobility limitations in musculoskeletal disorders such as piriformis syndrome.
Measured: 4 Weeks
Secondary outcomes (2)
FAIR Test
The FAIR (Flexion, Adduction, and Internal Rotation) test is a provocation test specifically designed for diagnosing piriformis syndrome. It reproduces symptoms by stretching the piriformis muscle, The FAIR (Flexion, Adduction, and Internal Rotation) test is a provocation test specifically designed for diagnosing piriformis syndrome. It reproduces symptoms by which may compress or irritate the sciatic nerve. The FAIR (Flexion, Adduction, and Internal Rotation) test is a provocation test specifically designed for diagnosing piriformis syndrome. It reproduces symptoms by sciatic nerve. This test has been validated as a reliable diagnostic too has been validated as a reliable diagnostic tool in piriformis-related case
Measured: 4 Weeks
Slump Test
The Slump test is a neurodynamic examination used to assess neural tension, particularly performed by placing the patient in a seated slumped tension, particularly slumped position with controlled spinal and limb movements, helping to reproduce neurological symptoms The Slump test is a neurodynamic examination used to assess neural of the sciatic nerve. It is performed with controlled spinal and limb movements, helping to reproduce neurological symptoms associated with lumbosacral or piriformis with controlled spinal and limb movements, helping to reproduce neurological symptoms associated with lumbosacral or piriformis-related condition.
Measured: 4 Weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Jan 2026
- Study start1 Mar 2025
- Primary completion30 Mar 2026
- Study completion30 Aug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Piriformis SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 42 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Danyal Ahmad
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Danyal Ahmad, University of Management and Technology Sialkot Pakistan
- Investigators
- HAMZA ZAHID, MS OMPT, Principal investigator, University of Management and Technology Sialkot Pakistan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07322185
- Sponsor's protocol ID
- kuhs/dpt/umt-skt-026
- Acronym
- Piriformis
- Status last verified
- Aug 2026
- First submitted
- 22 Dec 2025
- Last updated
- 12 Aug 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 12 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- COMPARATIVE EFFECTS OF STECCO-FASCIAL MANIPULATION AND ROLFING STRUCTURAL INTEGRATION IN PATIENTS WITH PIRIFORMIS SYNDROME; A RANDOMIZED CLINICAL TRIAL
- ClinicalTrials.gov ID
- NCT07322185
- Acronym / sponsor ID
- Piriformis / kuhs/dpt/umt-skt-026
- Conditions
- Piriformis Syndrome
- Keywords
- Stecco-fascial Manipulation, Rolfing Structural Integration, Piriformis Muscle Syndrome, Manual Lymphatic Drainage, Muscle Recruitment
- Study type
- Interventional
- Recruitment status
- Enrolling by invitation
- Enrolment
- 42 participants (estimated)
- Lead sponsor
- Danyal AhmadUniversity, hospital or other
- Study start
- 1 Mar 2025 (actual)
- Primary completion
- 30 Mar 2026 (actual)
- Study completion
- 30 Aug 2026 (estimated)
- First posted
- 7 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to compare the effectiveness of Stecco Fascial Manipulation and Rolfing Structural Integration in treating Piriformis syndrome, focusing on special outcomes like pain severity and functional outcomes.
comparison will be done to check the effectiveness of Stecco-fascial Manipulation and Rolfing Structural Integration on patients of both groups.
participants will:
- get the treatment according to their respective groups
- Both groups were given 4 sessions for 4 weeks.
Detailed description
This study will be a randomized clinical trial with a sample size of 42 participants as calculated with g power tool with 5% of attrition added. Subjects will be obtained by non- probability convenient sampling based on the inclusion and exclusion criteria. Participants will be randomly assigned into two groups, 21 subjects in each group. The group A will receive the stecco fascial manipulation along with the conventional therapy while group B will receive the rolfing structural integration along with conventional therapy. The conventional physiotherapy protocol will include TENS applied with a Hot- pack for 10 minutes that will be followed by piriformis stretch.The data analysis will be done by IBM SPSS 26.0 version. To check the normality Shaprio- Wilk test will be used.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| GROUP A ( Stecco fascial Manipulation) | Experimental | Other: Experimental: GROUP A ( Stecco fascial Manipulation)GROUP A ( Stecco fascial Manipulation) containing 21 participants who will be given Stecco fascial Manipulation for 30 minutes along with the conventional physiotherapy. |
| GROUP B (Rolfing Structural Integration) | Experimental | Other: Experimental: GROUP B (Rolfing Structural Integration)GROUP B (Rolfing Structural Integration) containing 21 participants who were given Rolfing Structural Integration for 30 minutes along with the conventional physiotherapy. |
Who may qualify
- Ages
- 25 to 45 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- 25 to 45 age group.
- For at least four weeks, there has been unilateral buttock discomfort, either with or without posterior thigh pain included buttock pain, pain that worsened when sitting.
- Positive slump test and fair test decrease ranges of hip NPRS greater than
Key exclusion criteria (3 listed)
- Previous pelvic, ipsilateral hip, lumbar, or sacroiliac surgery that would have confused pain source.
- Evidence of lumbar radiculopathy or another spinal condition that could be the origin of the symptoms (matching MRI/CT revealing nerve root compression or disc herniation). progressive neurologic disease or neuromuscular disease (e.g., peripheral neuropathy, myopathy, neuromuscular junction diseases)28.
- During the research period, pregnancy or the planning of pregnancy (if interventions are employed) active pelvic or hip infection, malignancy, fracture, or systemic inflammation.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Experimental: GROUP A ( Stecco fascial Manipulation)Stecco-fascial manipulation primary reduces pain, improves range of motion, restores normal muscle recruitment link in myofascial sequences, facilitates healing by improving microcirculation and lymphatic drainage. | Other | GROUP A ( Stecco fascial Manipulation) |
| Experimental: GROUP B (Rolfing Structural Integration)Rolfing structural integration improves posture, reduces pain, lengthens fascial planes and enhances the movement efficiency. This research will determine which approach is more effective in treating the patient with piriformis syndrome. | Other | GROUP B (Rolfing Structural Integration) |
Primary outcome
Change From Baseline in Pain Intensity as Measured by the Numerical Pain Rating Rating Scale (NPRS)
Time frame: 4 Weeks
The Numerical Pain Rating Scale (NPRS) is a self-intensity on an 11-point scale, ranging from 0 (no pain) to 10 (worst possible pain). It is widely used in both clinical and research demonstrated strong reliability and validity in measuring Scale (NPRS) is a self-reported tool used to assess pain point scale, ranging from 0 (no pain) to 10 (worst possible pain). It is research settings for musculoskeletal conditions, strong reliability and validity in measuring both acute and chronic pain reported tool used to assess pain point scale, ranging from 0 (no pain) to 10 (worst possible pain). It is conditions, and it has both acute and chronic pain
Universal Goniometer
Time frame: 4 Weeks
A goniometer is an instrument used objective and reliable values that help evaluate mobility limitations i disorders such as piriformis syndrome used to measure joint range of motion (ROM). It provides objective and reliable values that help evaluate mobility limitations in musculoskeletal disorders such as piriformis syndrome.
2 secondary outcomes
FAIR Test
Time frame: 4 Weeks
Slump Test
Time frame: 4 Weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Aug 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Piriformis Syndrome
Not yet recruitingPhase 2
Efficacy of Botulinum Toxin Versus Placebo on Pain and Health Related Quality of Life of Patients With Piriformis Muscle Syndrome
Piriformis Muscle Syndrome
Recruiting
Interfascial Hydrodissection Added to Ultrasound-Guided Piriformis Injection for Piriformis Syndrome
Piriformis Syndrome
Recruiting
Comparative Effects of Post-Isometric Relaxation and Reciprocal Inhibition Techniques inPiriformis Syndrome
Piriformis Syndrome
Enrolling by invitation
Neural Gliders With and Without ESWT for Deep Gluteal Syndrome
Deep Gluteal Syndrome
Enrolling by invitation
Comparative Effects of the Bowen Technique With and Without Extracorporeal Shock Wave Therapy in Patients With Deep Gluteal Syndrome
Deep Gluteal Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
HAMZA ZAHID, MS OMPT principal investigator
University of Management and Technology Sialkot Pakistan
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Experimental: GROUP A ( Stecco fascial Manipulation) and Experimental: GROUP B (Rolfing Structural Integration) in people with Piriformis Syndrome, run by Danyal Ahmad at 3 sites in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 12 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change From Baseline in Pain Intensity as Measured by the Numerical Pain Rating Rating Scale (NPRS) (time frame: 4 Weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2026.